Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 3—March 2012
CME ACTIVITY - Research

Community-associated Clostridium difficile Infections, Monroe County, New York, USA

Ghinwa DumyatiComments to Author , Vanessa Stevens, George E. Hannett, Angela D. Thompson, Cherie Long, Duncan MacCannell, and Brandi Limbago
Author affiliations: University of Rochester, Rochester, New York, USA (G. Dumyati, V. Stevens); State University of New York at Buffalo, Buffalo, New York, USA (V. Stevens); New York State Department of Health, Albany, New York, USA (G.E. Hannett); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (A.D. Thompson, C. Long, D. MacCannell, B. Limbago)

Main Article

Figure 2

Metronidazole MICs (μg/mL) for North American pulsed-field 1 (NAP1) strains of Clostridium difficile compared with MICs for other strains, Monroe County, New York, USA, March 1–August 2008. tox, toxinotype.

Figure 2. Metronidazole MICs (μg/mL) for North American pulsed-field 1 (NAP1) strains of Clostridium difficile compared with MICs for other strains, Monroe County, New York, USA, March 1–August 2008. tox, toxinotype.

Main Article

Page created: February 23, 2012
Page updated: February 23, 2012
Page reviewed: February 23, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external